Parathyroid hormone (PTH) provides anabolic therapy for osteoporosis clinically as it has been documented to increase bone mineral density and to reduce the rate of fractures in patients with osteoporosis and also improve fragility fracture-healing (Goltzman, 2018). This evidence concerns the gene PTH and osteoporosis.